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Abstract
Background: Although gastric cancer has declined dramatically in the US, the disease remains the second leading cause of
cancer mortality worldwide. A better understanding of reasons for the decline can provide important insights into effective
preventive strategies. We sought to estimate the contribution of risk factor trends on past and future intestinal-type
noncardia gastric adenocarcinoma (NCGA) incidence.
Methods and Findings: We developed a population-based microsimulation model of intestinal-type NCGA and calibrated it
to US epidemiologic data on precancerous lesions and cancer. The model explicitly incorporated the impact of Helicobacter
pylori and smoking on disease natural history, for which birth cohort-specific trends were derived from the National Health
and Nutrition Examination Survey (NHANES) and National Health Interview Survey (NHIS). Between 1978 and 2008, the
model estimated that intestinal-type NCGA incidence declined 60% from 11.0 to 4.4 per 100,000 men, ,3% discrepancy
from national statistics. H. pylori and smoking trends combined accounted for 47% (range=30%–58%) of the observed
decline. With no tobacco control, incidence would have declined only 56%, suggesting that lower smoking initiation and
higher cessation rates observed after the 1960s accelerated the relative decline in cancer incidence by 7% (range=0%–
21%). With continued risk factor trends, incidence is projected to decline an additional 47% between 2008 and 2040, the
majority of which will be attributable to H. pylori and smoking (81%; range=61%–100%). Limitations include assuming all
other risk factors influenced gastric carcinogenesis as one factor and restricting the analysis to men.
Conclusions: Trends in modifiable risk factors explain a significant proportion of the decline of intestinal-type NCGA
incidence in the US, and are projected to continue. Although past tobacco control efforts have hastened the decline, full
benefits will take decades to be realized, and further discouragement of smoking and reduction of H. pylori should be
priorities for gastric cancer control efforts.
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Gastric cancer (GC) is the second most common cause of
cancer-related deaths worldwide, responsible for an estimated
700,000 deaths each year (10.4% of all cancer deaths) [1]. Based
on current age-specific rates of GC and projected demographic
changes, the annual number of expected deaths worldwide will
increase to 1.4 million in 2030. Once diagnosed, the prognosis and
treatment options are poor, with less than 27% surviving more
than 5 y [2]. Reducing GC incidence through modification of risk
factors may therefore be the most effective way to reduce GC
mortality.
In the US, GC was the leading cause of cancer-related deaths
among men in the early 1900s. While it has fallen dramatically
since then, the precise reasons for the ‘‘unplanned triumph’’ are
not well-established [3], though broadly attributed to improve-
ments in living conditions and availability of refrigeration. The
decline has been more pronounced for noncardia cancers, in
particular intestinal-type tumors for which H. pylori infection is the
leading risk factor [4]. Recent evidence suggests that cardia
cancers may be increasing in frequency [5,6]. Although histologic
subtypes are sometimes difficult to distinguish, these trends in
cancer incidence may suggest possible differences in tumor
biology.
Intestinal-type noncardia gastric adenocarcinoma (NCGA),
which accounts for over 50% of all GC cases in the US [7],
develops through a series of relatively well-defined histological
steps over several decades [8], and the influence of H. pylori and
smoking influence on the carcinogenesis process have been well-
described by epidemiologic studies [9–14]. By initiating the
precancerous process, H. pylori infection increases intestinal-type
NCGA risk by as much as 6-fold [10], while smoking elevates
cancer risk by 2-fold by increasing progression risk of existing
lesions to more advanced lesions [15]. As intestinal-type NCGA
incidence has fallen over the past century, prevalence of both
risk factors has also drastically changed. Only 33% of adults are
currently infected with H. pylori [16], and after peaking to more
than 50% in the 1955, smoking rates have declined to 20% since
the 1964 publication of the first US Surgeon General’s Report
on Smoking and Health [17–19]. Other risk factors, including
genetic factors and diet (e.g., low intake of fresh fruits and
vegetables and/or high salt intake), are also important, although
their effects on the gastric carcinogenesis are less well-
understood.
Understanding the combined effects of underlying risk factor
trends on population-level intestinal-type NCGA outcomes can
help to predict future cancer trends and burden in the US and
globally. While data on H. pylori prevalence and smoking rates in
the US are available from the National Health and Nutrition
Examination Survey (NHANES) [16] and National Health
Interview Survey (NHIS) [18], these databases do not contain
information on GC. Similarly, the Surveillance, Epidemiology and
End Results (SEER) Program provides estimates of population-
based cancer incidence, but lacks data on risk factors.
We employ a mathematical modeling framework capable of inte-
grating available epidemiologic, clinical, and demographic data to
understand the effect of risk factor trends on past and future
population-level intestinal-type NCGA incidence rates among US
men. Specifically, we aim to estimate the contribution of H. pylori and
smoking trends on the decline in cancer incidence and explore the
magnitude by which anti-smoking campaigns following the US
Surgeon General’s 1964 Report on Smoking and Health accelerated
the decline.
Methods
Overview
We developed a population-based microsimulation model of
intestinal-type NCGA to estimate the impact of observed risk factor
trends on past and future cancer incidence for US men (Figure 1).
We focused on this subset of GCs, defined by criteria proposed and
used by Lauren [20], Henson et al., [21], and Wu et al. [22], as the
precancerous process and role of risk factors for this histologically
distinct subgroup of distally located tumors has been well-
established. The model explicitly incorporated the impact of H.
pylori and smoking on disease natural history. To accomplish this,
birth cohort trends were derived from NHANES and NHIS data,
and the model was calibrated to US data on precancerous lesions
and cancer to ensure model predictions were consistent with
epidemiologic data. Using the model, we projected population-
based intestinal-type NCGA outcomes between 1978 and 2040 in
which all risk factortrends wereallowedto vary over time (base-case
scenario). We then used the model to evaluate alternative risk factor
scenarios to provide insights on the potential benefit of past and
future GC control efforts.
Intestinal-Type NCGA Natural History Microsimulation
Model
To allow for greater flexibility in capturing multiple dimensions
of heterogeneity, we refined a previously described intestinal-type
NCGA natural history model [23] to function as a microsimula-
tion model that simulates individuals within multiple 5-y birth
cohorts (born between 1881 and 2025) to generate population-
based cancer outcomes for men between 1978 and 2040. In the
model, intestinal-type NCGA develops through a series of
precancerous lesions, which may progress to dysplasia and
eventually invasive cancer (Figure 2). At the start of the simulation,
20-y-old individuals are assigned a birth cohort-specific risk factor
profile and enter the model. Each month, using rates derived via
previously described model calibration methods (see Table 1 and
Text S1) [23], individuals face a risk of progression among the
health states. On the basis of epidemiologic studies, we assumed
that in addition to causing gastritis, H. pylori increases the risk of
atrophy [9], while smoking increases the risk of progression to
intestinal metaplasia and dysplasia [11,12].
For each individual, we assigned H. pylori status at age 20 based
on NHANES data (Figure 3). As H. pylori infection is acquired in
childhood and persists unless treated with antibiotics [24,25], we
assumed that an individual’s status remained unchanged through-
out their lifetime. Smoking profiles for each individual, including
initiation and cessation age, were derived from the NHIS-based
Smoking History Generator (SHG) developed by the National
Cancer Institute (NCI) Cancer Intervention and Surveillance
Modeling Network (CISNET) (Figure 3) [26,27]. As the impact of
smoking on disease progression varies by intensity [11,12], we
categorized smokers into four subgroups: low (,10 cigarettes per
day [CPD]), moderate (10–19 CPD), heavy ($20 CPD), and
former smokers. The effect of smoking cessation on disease
progression was also assumed to be immediate upon quitting, with
progression rates declining and remaining at former smoker levels.
Given the multifactorial etiology of intestinal-type NCGA,
factors other than H. pylori and smoking have contributed to the
observed decline in cancer incidence. As such, we allowed birth
cohort-specific disease risk to vary over time, an approach
commonly used in population-based microsimulation models
[28]. Specifically, as multi-stage models of gastric carcinogenesis
suggest exposures early on are likely responsible for incidence
declines among successive birth cohorts [3,8,29], we operationa-
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rate of decline on the risk of developing atrophy beginning with
the 1901 birth cohort.
To reflect changes in all-cause background mortality, we used
birth cohort-specific life tables obtained from the Berkeley Mortality
Database (http://www.demog.berkeley.edu/,bmd/) and US So-
cial Security Administration [30], and adjusted for smoking
intensity using relative risk estimates from the American Cancer
Society Cancer Prevention Study II (CPS-II) (see Text S1) [31].
Model Outcomes and Uncertainty Analysis
Model outcomes included age-standardized incidence, number
of annual cases, and number of total cases for intestinal-type
NCGA. For age-standardized cancer incidence, we used the US
2000 standard population for comparability to SEER estimates
(assuming cancer risk among individuals less than 20 y old was
negligible) [32]. For annual number of cases, we incorporated
population size estimates from the US Census Bureau into the
model to reflect the impact of population growth and ageing on
cancer cases [33]. The model also projected the prevalence of
precancerous lesions among individuals 20 y and older.
To reflect the impact of disease natural history uncertainty on
modeled outcomes, using previously described calibration methods
[23], we identified multiple parameter sets that fit equally well to
epidemiologic data on age-specific precancerous lesions prevalence
[34] and GC incidence [7]. Among the good-fitting parameter sets
identified, we randomly selected a subset of 50 parameter sets for
this analysis and report the mean and range (minimum, maximum)
for all model outcomes. See Text S1 for additional details on model
development and calibration.
Intestinal-Type NCGA Projections between 1978 and
2040: Scenarios
For our base-case scenario, we incorporated all observed risk
factor trends and projected intestinal-type NCGA outcomes over
two time periods: 1978–2008 and 2008–2040. To explore the
impact of alternative risk factor scenarios, we re-ran the model for
several other risk factor scenarios and compared model outcomes
with the base-case scenario. First, to estimate the combined
Figure 1. Overview of model-based approach. This figure depicts
the three components of our trend analysis: (1) development of a
population-based intestinal-type NCGA microsimulation model, which
explicitly incorporates birth cohort-specific risk factor trends, background
mortality rates, and population size, and identifies natural history
progression rates via model calibration to US epidemiologic data; (2)
projection of intestinal-type NCGA outcomes between 2008 and 2040 for
the base case (all risk factor trends) using a subset of 50 randomly selected
good-fitting parameter sets (identified via model calibration); and (3)
estimation of intestinal-type NCGA outcomes under alternative risk factor
or tobacco control scenarios for insights on GC control.
doi:10.1371/journal.pmed.1001451.g001
Figure 2. Intestinal-type NCGA model diagram. Intestinal-type NCGA develops through a series of precancerous health states as depicted. Each
month, individuals face a risk of progression among the health states. Before invasive cancer develops, individuals can also regress to less advanced
precancerous lesions. Individuals with preclinical (asymptomatic) cancer can remain asymptomatic or progress to symptomatic clinical cancer. Once
individuals develop symptomatic cancer, they are assumed to receive treatment and do not progress to more advanced cancer states. All
probabilities are constant, except for the age-specific transition from dysplasia to preclinical cancer.
doi:10.1371/journal.pmed.1001451.g002
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over time, we allowed only H. pylori and smoking trends to vary
(e.g., ‘‘all other risk factors’’ halted at pre-1900 levels). We also
estimated the contribution of individual risk factors by allowing
each risk factor to vary (i.e., H. pylori) while holding the rates of the
other two risk factors (i.e., smoking patterns and ‘‘all other risk
factors’’) constant at pre-1900 birth cohort levels.
For insight on the relative impact of the lower smoking initiation
and higher cessation rates that were observed after the 1964
Report on Smoking and Health [19], we evaluated two additional
hypothetical scenarios, previously described in the context of lung
cancer [28,35]: (1) no tobacco control, in which mid-century
tobacco control efforts were assumed to have never been
implemented, and (2) complete tobacco control, in which all
smoking ceased abruptly in 1965, with all smokers quitting
permanently in 1965 and no smoking initiation after 1964.
For each scenario, we calculated the percent decline in cancer
incidence over two time periods: 1978–2008 and 2008–2040. To
understand the effects of risk factors and tobacco control, we also
report the relative contribution of alternative risk factor scenarios
to the base-case scenario decline in cancer incidence (defined as
the risk factor scenario percent decline divided by base-case
scenario percent decline, and reported as a percentage).
Results
Age-Standardized Intestinal-Type NCGA Incidence
Historical trends, 1978 to 2008. For our base case,
reflecting all observed risk trends, the model estimated that the
age-standardized intestinal-type NCGA incidence declined from
11.0 to 4.4 per 100,000 men between 1978 and 2008 (60%
decline), less than a 3% discrepancy with SEER estimates for that
period (Table 2) [7].
When only observed H. pylori prevalence and smoking trends
were incorporated in the model (e.g., ‘‘all other risk factors’’ held
constant at pre-1900 birth cohort levels), intestinal-type NCGA
incidence decreased by 28% (12.7 to 9.2 per 100,000 men). This
suggests that H. pylori and smoking trends are responsible for 47%
(range=30%–58%) of the observed cancer decline (Figure 4).
Evaluated individually, H. pylori (43%; range=35%–48%) and ‘‘all
other risk factors’’ (82%; range=70%–93%) were responsible for a
significant proportion of the cancer decline; in contrast, smoking
was responsible for a much smaller fraction (3%; range=0%–
17%). Among the 50 good-fitting parameter sets, the proportion
attributable to ‘‘all other risk factors’’ was consistently greater than
for H. pylori, and the proportion for H. pylori was greater than for
smoking.
Under the ‘‘no tobacco control’’ scenario, the model estimated
that age-standardized intestinal-type NCGA incidence declined
56% (11.4 to 5.0 per 100,000 men) (Figure 4). This finding
suggests that the lower smoking initiation and higher cessation
rates observed after the 1960s accelerated the relative decline in
intestinal-type NCGA incidence by 7% (calculated as the base case
percent decline divided by the ‘‘no tobacco control’’ percent
decline=107.4); the relative decline ranged from 0% to 21%
among the 50 good-fitting parameter sets. Under the ‘‘complete
tobacco control’’ scenario, compared with the base case, the
relative decline in intestinal-type NCGA incidence would have
been greater by 6% (range=0%–14%) (Figure 4).
Projected trends, 2008 to 2040. For the base case, with
continuation of risk factor trends, intestinal-type NCGA incidence
is projected to decline an additional 47% between 2008 and 2040
(4.4 to 2.3 per 100,000 men) (Table 2). During this period, H. pylori
and smoking trends would account for 81% (range=61%–100%)
of the observed cancer incidence decline. Evaluated separately,
trends in H. pylori (46%; range=35%–66%), smoking (42%;
range=29%–67%), and ‘‘all other risk factors’’ (40%;
range=12%–69%) would each account for a substantial propor-
tion of the projected decline. H. pylori trends were responsible for a
greater proportion of the observed decline in 22 of the 50 good-
fitting parameter sets (44%) than either of the other two risk
factors.
Under the ‘‘no tobacco control’’ scenario, the model projected
that between 2008 and 2040, intestinal-type NCGA incidence
Table 1. Intestinal-type NCGA model parameter values.
Parameter
a
Range Identified Via
Model Calibration
Natural history
Gastritis to atrophy 0.0001
Atrophy to intestinal metaplasia 0.0048–0.0200
Intestinal metaplasia to dysplasia 0.0005–0.0010
Dysplasia to preclinical cancer
Age 20–29 0.000000–0.000005
Age 30–39 0.000000–0.000009
Age 40–49 0.000004–0.00003
Age 50–59 0.0002–0.0003
Age 60–69 0.0004–0.0008
Age 70–79 0.0007–0.0018
Age 80–89 0.0011–0.0034
Age 90+ 0.0016–0.0066
Preclinical to clinical cancer 0.0410–0.0830
Dysplasia to intestinal metaplasia 0.0051–0.0090
Intestinal metaplasia to atrophy 0.0001–0.0086
Atrophy to gastritis 0.0005–0.0099
Clinical cancer detection
Local 0.006–0.014
Regional 0.024–0.056
Distant 0.034–0.400
Risk factors on disease
progression (relative risk)
H. pylori
Gastritis to atrophy 16.1–41.3
Smoking
Atrophy to intestinal metaplasia
b
,20 cigarettes per day 1.1–3.7
$20 cigarettes per day 3.6–17.0
Former smoker 1.1–3.7
Intestinal metaplasia to dysplasia
b
,10 cigarettes per day 1.0–2.6
$10 cigarettes per day 2.1–2.8
Former smoker 1.0–2.6
All other risk factors
Gastritis to atrophy
c 0.039–0.098
aMonthly probabilities unless otherwise noted.
bRelative to non-smokers (RR=1).
cConstant exponential rate (r) of decline per birth cohort as described in the
following equation: (12r)‘t, where t=year of birth 2 1901.
doi:10.1371/journal.pmed.1001451.t001
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during this time period, smoking behavior changes beginning in
the 1960s would accelerate the relative decline in intestinal-type
NCGA incidence by 56% (range=20%–117%) (as compared to
7% [range=0%–21%] between 1978 and 2008). Similarly, had
‘‘complete tobacco control’’ occurred in 1965, the relative decline
in intestinal-type NCGA incidence between 2008 and 2040
would also be greater by 16% (range=0%–41%) (versus 6%
[range=0%–14%] between 1978 and 2008).
Number of Intestinal-Type NCGA Cases
Reflecting the combined effects of changing risk factor trends
and population growth and ageing on cancer outcomes (in
contrast to age-standardized cancer incidence), the model
estimated that between 1978 and 2008, the annual number of
intestinal-type NCGA cases for the base case fell by 33% (6,180 to
4,160 cases) (range=24%–41%) (Table 3). Between 2008 and
2040, the number of cases continued to decline by 10% (to 3,760
cases). As a result of the uncertainty in the combined effects of
continued risk factor trends and population growth, the percent
change among the 50 good-fitting parameter sets ranged from a
31% decline to a 12% increase during this period.
Under the ‘‘no tobacco control’’ scenario, the relative annual
number of intestinal-type NCGA cases decreased by 30%
(range=21%–38%) between 1978 and 2008, and by 12%
between 2008 and 2040 (Figure 5). Among the 50 good-fitting
Figure 3. Birth cohort risk factor profiles. (A) H. pylori prevalence at age 20 for birth cohorts between 1881 and 2020 based on NHANES III and
Continuous NHANES (1999–2000) data. For pre-1900 and post-1980 birth cohorts for which data were unavailable, we extrapolated the observed
7.1% rate of decline between successive 5-y birth cohorts between the 1901–1905 and 1976–1980. (B) The proportion of current smokers by 5-y birth
cohorts between 1891 and 2020 (starting at age 20). For birth cohorts born after 1983 (and cohorts with individuals still alive past calendar year 2000)
for which data from the NHIS-based Smoking History Generator were unavailable, we extrapolated observed trends and extended profiles until all
individuals either died or reached 100 y of age. Specifically, for post-1983 birth cohorts, we assumed that smoking rates peaked at age 20, initiation
rates declined by 5.7% every 5 birth cohort years, and the annual risk of cessation remained constant at 2% [54,55].
doi:10.1371/journal.pmed.1001451.g003
Risk Factors and the US Decline of NCGA
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Risk Factors and the US Decline of NCGA
PLOS Medicine | www.plosmedicine.org 6 May 2013 | Volume 10 | Issue 5 | e1001451Figure 4. Modeled age-standardized intestinal-type NCGA incidence between 1978 and 2040 for select scenarios. (A–C) Age-
standardized intestinal-type NCGA incidence for select scenarios. Mean (solid line) and range (shaded area) among the 50 randomly selected good-
fitting parameter sets are shown. (A) Cancer incidence for the base-case scenario (all risk factor trends) (black) and H. pylori and smoking only scenario
(light blue). (B) Cancer incidence for the base-case scenario (black) and ‘‘no tobacco control’’ scenario (light blue). (C) Cancer incidence for the base-
case scenario (black) and ‘‘complete tobacco control’’ scenario (light blue). Ranges were calculated across all 50 parameter sets and smoothed with a
3-y moving average.
doi:10.1371/journal.pmed.1001451.g004
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PLOS Medicine | www.plosmedicine.org 7 May 2013 | Volume 10 | Issue 5 | e1001451parameter sets, there was considerable uncertainty in the 2008–
2040 estimates, ranging from a relative 8% decrease to a relative
30% increase in annual number of cases. Compared to base-case
estimates, this suggests that anti-smoking efforts averted a total of
5,770 cases (3%; range=0%–7%) between 1978 and 2008, and
potentially as many as 22,470 cases (15%; range=6%–23%)
between 2008 and 2040. Had ‘‘complete tobacco control’’ in 1965
been possible, compared to the base-case scenario, an additional
19,890 cases (7%; range=0.2%–13%) could have been potentially
averted during the overall 1978 to 2040 time period (Figure 5).
Prevalence of Precancerous Gastric Lesions
Between 1978 and 2008, the model estimated that age-
standardized prevalence of intestinal metaplasia and dysplasia
both declined by approximately 50% between 1978 and 2008
(intestinal metaplasia range=41%–56%; dysplasia range=48%–
58%). The decline is projected to continue, though at slower rates
between 2008 and 2040 (intestinal metaplasia range=20%–39%;
dysplasia range=30%–46%) (Figure 6).
Discussion
The US decline in GC has been remarkable over the past
century. While H. pylori is estimated to be responsible for the
majority of distal tumors [36], the effect of declining childhood
infection rates on intestinal-type NCGA over time has not been
previously estimated. Incorporating the best available epidemio-
logic, etiologic, and demographic data, our microsimulation model
analysis suggests that, in combination with changes in smoking
patterns, nearly 50% of the observed cancer decline between 1978
and 2008 is attributable to the decline in H. pylori infection rates.
Further, the decline in cancer incidence is projected to continue
through 2040, with the contribution of H. pylori and smoking
increasing to 80%. As with intestinal-type NCGA risk, the absolute
number of cancer cases has also declined each year, though at a
projected slower rate between 2008 and 2040 due to the combined
effects of continued risk factor trends and demographic changes.
Our model-based findings highlight the challenges and successes
of prevention efforts for GC. We found that a significant time lag
exists between the implementation of any risk factor modification
and population-level effects, even those that target progression
rates of advanced lesions. For example, our model estimated that
following the US Surgeon General’s first report on the
consequences of smoking, tobacco control efforts beginning in
the mid-1960s accelerated the decline in intestinal-type NCGA
incidence by only 7% between 1978 and 2008. However, in the
following 22-y period, the decline may increase by 8-fold to 56%.
In addition, we estimate that tobacco control efforts will avert 9%
(28,000 cases) of intestinal-type NCGA cases between 1978 and
2040. In conjunction with the estimated 34% of lung cancer
deaths averted among men between 1975 and 2000 [28], our
estimates for GC provide further evidence of the health benefits of
tobacco control.
Several other important insights can be gained from our
findings. First, compared to smoking, the contribution of H. pylori
on the decline in intestinal-type NCGA was several-fold greater
between 1978 and 2008, but equal in magnitude between 2008
and 2040, reflecting the differential time trends for each risk factor.
H. pylori prevalence began to decline in the early 1900s while
smoking rates increased until the mid-1950s and declined in the
following decades. In addition, the sum of the individual
contributions for H. pylori and smoking exceeded the decline
estimated with both concurrent trends. This illustrates the
underlying risk factor dynamics on gastric carcinogenesis. Because
H. pylori affects disease progression early on, and smoking at more
advanced stages, as H. pylori prevalence declines, fewer people
develop advanced lesions and benefit from lower smoking rates. As
such, reductions in these two risk factors do not appear to be
additive in their effects on cancer incidence, which is consistent
with each risk factor influencing a different but sequential step in
gastric carcinogenesis. These findings could have significant
implications for GC control strategies.
Second, we attempted to calibrate our model by incorporating
only H. pylori and smoking trends, but were unable to fit to the
decline observed in SEER between 1978 and 2008 until we
allowed the probability of developing atrophy to decline
exponentially among consecutive 5-y birth cohorts. This finding
suggests that changes in other risk factors are needed to explain the
decline in intestinal-type NCGA incidence over time, and,
according to our model, specifically risk factors that changed
substantially during the first half of the 20th century. Availability
of refrigeration may be one of these risk factors. Rates of US
refrigeration rose steadily during the early 20th century [3], and
data from Japan suggest that GC mortality rates declined as the
proportion of households with refrigeration increased [37]. The
underlying mechanism of refrigeration on intestinal-type NCGA
risk likely stems from reduced salt consumption, and possibly
increased intake of fresh fruits and vegetables [38]. Consistent with
our findings, clinical studies suggest that the salt intake may act
synergistically with H. pylori to promote the development of GC
Table 3. Modeled intestinal-type NCGA outcomes between 1978 and 2040: annual number of cancer cases and percent change in
number of cases.
Scenarios Annual Number of Intestinal-Type NCGA Cases
Percent Change in Annual Number of Intestinal-
Type NCGA Cases, Mean (Range)
a
Historical Projected
b
1978 2008 2040 1978–2008 2008–2040
Base case (all risk factors) 6,180 4,160 3,760 232.7 (223.7 to 240.8) 29.8 (230.9 to 12.4)
H. pylori and smoking only 7,510 8,770 9,050 16.8 (4.9 to 30.0) 3.3 (212.7 to 22.2)
No tobacco control 6,380 4,450 4,960 230.3 (220.9 to 238.1) 11.7 (27.9 to 29.6)
Complete tobacco control 5,940 3,910 3,050 234.2 (225.1 to 241.8) 222.0 (258.3 to 8.6)
aAmong the 50 randomly selected good-fitting natural history parameter sets identified via calibration.
bRange for percent change included both positive and negative estimates, reflecting the uncertainty of the combined effects of continued risk factor trends and
population growth on annual intestinal-type NCGA cases.
doi:10.1371/journal.pmed.1001451.t003
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PLOS Medicine | www.plosmedicine.org 8 May 2013 | Volume 10 | Issue 5 | e1001451[39–42]. In addition, our model suggests that H. pylori is largely
responsible for the progression of gastritis to atrophy (relative risk
ranged from 16 to 41 among the good-fitting natural history
parameter sets identified via model calibration).
Other risk factors that may explain the observed decline in
intestinal-type NCGA include genetic profiles, virulence of H.
pylori strain, and bacterial/host genotypic features [43]. However,
these factors are not likely to have dramatically changed over time.
Use of histamine-2-reception antagonists and proton pump
inhibitors, the most common treatment for gastric acid production
reduction, has changed over time. Yet evidence on the associated
intestinal-type NCGA risk for these pharmacological treatments is
inconclusive [44]. In addition, with both not having been
introduced until the 1970s or 1980s, they are unlikely to explain
the decrease in risk that our model suggestions should have started
in the early 1900s.
Third, our model demonstrates the importance of considering
the temporal relationships between risk factor changes and the
attainment of long-term benefits on cancer outcomes. As the
decline in H. pylori infection rates (albeit at different rates) and the
tobacco epidemic are global phenomena, and the multifactorial
etiology of intestinal-type NCGA is largely driven by these two risk
Figure 5. Modeled annual intestinal-type NCGA cases between 1978 and 2040 for select scenarios. These figures show the number of
annual incident intestinal-type NCGC cases. Mean (solid line) and range (shaded area) among the 50 randomly selected good-fitting parameter sets
are shown. (A) Cancer cases for the base-case scenario (black) and ‘‘no tobacco control’’ scenario (light blue). (B) Cancer cases for the base-case
scenario (black) and ‘‘complete tobacco control’’ scenario (light blue). Ranges were calculated across all 50 parameter sets and smoothed with a 3-y
moving average.
doi:10.1371/journal.pmed.1001451.g005
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PLOS Medicine | www.plosmedicine.org 9 May 2013 | Volume 10 | Issue 5 | e1001451factors, our findings provide important insight on the potential
expected declines in other countries and may be in particular
generalizable for countries experiencing similar risk factor trends.
Because of the variability in risk factor trend magnitude and
timing, the contribution of H. pylori and smoking to the decline of
cancer incidence will depend on country-specific trends and the
underlying temporal relationship between the risk factors. For
example, countries experiencing declines in H. pylori prevalence
during the initial stages of the tobacco epidemic (where uptake of
smoking has not yet plateaued) will likely have smaller reductions
in cancer outcomes than countries that are undergoing declines in
both risk factors at the same time. The influence of other risk
factor trends in each country will be an important consideration as
well.
Fourth, recent trend analyses suggest that while age-standard-
ized NCGA rates are declining overall [6,22,45–47], age-specific
rates may be increasing [6,45]. Our analyses found that among
younger individuals, age-specific intestinal-type NCGA rates have
declined and are projected to continue to decline because of H.
pylori, smoking, and other risk factor trends. This was true even in
the ‘‘no tobacco control’’ scenario (see Text S1). The increase is
likely not related to changes (or rather lack of changes) in smoking
behaviors. We also found that along with age-standardized
intestinal-type NCGA incidence, prevalence of intestinal metapla-
sia and dysplasia has significantly declined over time. This is
relevant from a clinical standpoint as the rise in gastroesophageal
reflux disease (GERD) and endoscopy use has resulted in detection
of incidental precancerous lesions. Our model suggests that with
continued risk factor trends, between 2008 and 2040, the
prevalence will not vary greatly for intestinal metaplasia (4%–
6%) or dysplasia (,1%), and are similar to estimates for the
Netherlands (9.5% and 0.7% in 2004).
While simulation modeling has been used to better understand
the impact of lifestyle changes and cancer control measures on
colorectal [48], lung [28], and breast cancer [49] incidence and
mortality, our approach has several limitations. First, we assumed
all other risk factors influenced gastric carcinogenesis as one factor
early on in the precancerous process. Other environmental factors,
or rather a combination, may in reality have affected the
probability of developing atrophy and/or other disease transitions
over time. Smoking may have affected gastric carcinogenesis at
other points as well. As data on additional risk factors and their
impact on precancerous process become available, our model can
be updated and revised to reflect these changes. In particular,
incorporating salt intake or other dietary risk factors into the
model may help to further understand the contribution of risk
factor changes to the decline in cancer incidence. We focused only
on intestinal-type NCGA, and H. pylori and smoking affect the risk
for other types of GC, including mucosa-associated lymphoid
tissue (MALT) lymphomas [50]. However, a strength of our study
is to look specifically at trends in noncardia intestinal gastric
adenocarcinoma, as previous descriptive studies of SEER have
been unable to examine trends by individual subsite or by Lauren
classification due to incomplete reporting and small numbers [45].
In addition, our natural history parameters are based on model
calibration, and are surrounded by uncertainty. We sought to
explicitly capture the impact of natural history uncertainty on
modeled outcomes by using a random subset of 50 good-fitting
parameter sets to provide upper and lower bounds of results. Our
model-based approach required several simplifying assumptions,
such as assuming the effect of smoking cessation on disease
progression rates was immediate or that the relative risk associated
with smoking for background mortality was constant across birth
cohorts, but were based on the best data available [11,12,31]. Birth
cohort risk factor trends were estimated from national surveys,
which may be biased and underestimate the true prevalence of H.
pylori or smoking. For example, we also did not account for changes
in H. pylori treatment and/or endoscopy rates, which may have
caused us to underestimate the proportion of intestinal-type NCGA
incidence attributable to changes in H. pylori prevalence.
Figure 6. Age-standardized prevalence of precancerous lesions between 1978 and 2040. For individuals 20 y and older, age-standardized
prevalence of intestinal metaplasia (dark blue) and dysplasia (light blue) are shown in this graph. Mean (solid line) and range (shaded region) among
the 50 randomly selected good fitting parameter sets are shown to reflect the impact of natural history uncertainty on prevalence estimates.
doi:10.1371/journal.pmed.1001451.g006
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prevalence has been similar, the smoking epidemic among women
has been quite distinct from men [51,52]. Absolute intestinal-type
NCGA risk is also lower among women [2]. As such, our results
likely provide an upper bound estimate on the proportion of
intestinal-type NCGA incidence among women attributable to
declining H. pylori and smoking trends; specific analyses are needed
to provide more accurate estimates for women and the overall
population. In addition, our projections may not fully account for
the impact of projected rates of immigration of individuals from
high GC risk countries. As GC risk is largely determined by
exposures early on in life, cancer projections may be especially
sensitive to the increasing proportion of individuals who migrate to
the US after childhood, particularly if their risk factor profiles
differ from the average NHANES and NHIS patterns on which
our model was based. NHANES and NHIS data also suggest that
H. pylori [53] and smoking trends [51] have varied by race/
ethnicity, and it is unclear whether risk factor trends have widened
or narrowed observed disparities in intestinal-type NCGA risk. As
such, next steps in our efforts to provide a more comprehensive
understanding of the US decline of GC include expanding our
model-based approach to women and race/ethnicity subgroups by
incorporating underlying differential risk factor trends to explore
their combined effects on population-level cancer outcomes and
disparities.
In conclusion, trends in modifiable risk factors explain a
significant proportion of the decline of intestinal-type NCGA
incidence in the US, and will contribute to future decline. While
lower H. pylori infection rates have reduced cancer risk, other
environmental factors may be equally important. Although past
tobacco control efforts have hastened the decline, the full benefits
will take several decades to be realized, and further discourage-
ment of smoking and reduction of H. pylori infection should be
priorities for GC control efforts.
Supporting Information
Text S1 Additional supporting information.
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Background. Cancer of the stomach (gastric cancer) is
responsible for a tenth of all cancer deaths world-wide, with
an estimated 700,000 people dying from this malignancy
every year, making it the second most common cause of
global cancer-related deaths after lung cancer. Unfortunate-
ly, the projected global burden of this disease estimate that
deaths from gastric cancer will double by 2030. Gastric
cancer has a poor prognosis with only a quarter of people
with this type of cancer surviving more than five years. In
order to reduce deaths, it is therefore of utmost importance
to identify and reduce the modifiable risk factors associated
with gastric cancer. Smoking and chronic gastric infection
with the bacteria Helicobacter pylori (H. pylori), are known to
be two common modifiable risk factors for gastric cancer,
particularly for a type of gastric cancer called intestinal-type
noncardia gastric adenocarcinoma (NCGA), which occurs at
the distal end of the stomach and accounts for more than
half of all cases of gastric cancer in US men.
Why Was This Study Done? H. pylori initiates a
precancerous process, and so infection with this bacteria
can increase intestinal-type NCGA risk by as much as 6-fold
while smoking doubles cancer risk by advancing increasing
progression of existing lesions. Changes in these two risk
factors over the past century (especially following the US
Surgeon General’s Report on Smoking and Health in 1964)
have led to a dramatic decline in the rates of gastric cancer in
US men. Understanding the combined effects of underlying
risk factor trends on health outcomes for intestinal-type
NCGA at the population level can help to predict future
cancer trends and burden in the US. So in this study, the
researchers used a mathematical model to estimate the
contribution of H. pylori and smoking trends on the decline
in intestinal-type NCGA incidence in US men.
What Did the Researchers Do and Find? The researchers
used birth cohorts derived from data in two national
databases, the National Health and Nutrition Examination
Survey (NHANES) and National Health Interview Survey
(NHIS) to develop a population-based model of intestinal-
type NCGA. To ensure model predictions were consistent
with epidemiologic data, the researchers calibrated the
model to data on cancer and precancerous lesions and using
the model, projected population outcomes between 1978
and 2040 for a base-case scenario (in which all risk factor
trends were allowed to vary over time). The researchers then
evaluated alternative risk factors scenarios to provide
insights on the potential benefit of past and future efforts
to control gastric cancer.
Using these methods, the researchers estimated that the
incidence of intestinal-type NCGA (standardized by age) fell
from 11.0 to 4.4 per 100,000 men between 1978 and 2008, a
drop of 60%. When the researchers incorporated only H.
pylori prevalence and smoking trends into the model (both
of which fell dramatically over the time period) they found
that intestinal-type NCGA incidence fell by only 28% (from
12.7 to 9.2 per 100,000 men), suggesting that H. pylori and
smoking trends are responsible for 47% of the observed
decline. The researchers found that H. pylori trends alone
were responsible for 43% of the decrease in cancer but
smoking trends were responsible for only a 3% drop. The
researchers also found evidence that after the 1960s,
observed trends in lower smoking initiation and higher
cessation accelerated the decline in intestinal-type NCGA
incidence by 7%. Finally, the researchers found that
intestinal-type NCGA incidence is projected to decline an
additional 47% between 2008 and 2040 (4.4 to 2.3 per
100,000 men) with H. pylori and smoking trends accounting
for more than 80% of the observed fall.
What Do These Findings Mean? These findings suggest
that, combined with a fall in smoking rates, almost half of the
observed fall in rates of intestinal-type NCGA cancer in US
men between 1978 and 2008 was attributable to the decline
in infection rates of H. pylori. Rates for this cancer are
projected to continue to fall by 2040, with trends for both H.
pylori infection and smoking accounting for more than 80%
of the observed fall, highlighting the importance of the
relationship between risk factors changes over time and
achieving long-term reduction in cancer rates. This study is
limited by the assumptions made in the model and in that it
only examined one type of gastric cancer and excluded
women. Nevertheless, this modeling study highlights that
continued efforts to reduce rates of smoking and H. pylori
infection will help to reduce rates of gastric cancer.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001451.
N The National Cancer Institute gives detailed information
about gastric cancer
N The Gastric Cancer Foundation has information on gastric
cancer for patients and professionals
N Cancer Research UK explains types of gastric cancer
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